We are live on ! Find out more
BLFS icon

BioLife Solutions

169 hedge funds and large institutions have $850M invested in BioLife Solutions in 2023 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 63 increasing their positions, 48 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

552% more call options, than puts

Call options by funds: $411K | Put options by funds: $63K

200% more funds holding in top 10

Funds holding in top 10: 13 (+2)

46% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 13

31% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 48

23% more capital invested

Capital invested by funds: $690M → $850M (+$160M)

2% more funds holding

Funds holding: 165169 (+4)

1.42% more ownership

Funds ownership: 89.25%90.67% (+1.4%)

Holders
169
Holders Change
+4
Holders Change %
+2.42%
% of All Funds
2.69%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.05%
New
19
Increased
63
Reduced
48
Closed
13
Calls
$411K
Puts
$63K
Net Calls
+$348K
Net Calls Change
-$632K
Name Holding Trade Value Shares
Change
Change in
Stake
Lazard Asset Management
176
Lazard Asset Management
New York
-$44K -2,457 Closed
ZB
177
Zions Bancorporation
Utah
-$7.17K -394 Closed
NA
178
NewEdge Advisors
Louisiana
-$4.24K -233 Closed
IA
179
IFP Advisors
Florida
-$2K -62 Closed
SWA
180
Sutton Wealth Advisors
Florida
-$146 -8 Closed
CAL
181
Capital Advisors Ltd
Ohio
-$135 -6 -86%

BLFS Hedge Fund Activity: Q1 2023 in Review

169 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q1 2023, worth a combined $850M — up 23% from $690M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new BLFS positions and 13 closed out — a net gain of 6 holders — while 63 added to existing stakes and 48 trimmed.

The largest buyer was Park West Asset Management, adding an estimated $11.3M. The largest seller was Millennium Management, cutting an estimated $4.29M.

  • 169 institutional investors held BioLife Solutions (BLFS) as of Q1 2023, up from 165 in Q4 2022.
  • Funds reported $850M of BioLife Solutions stock for Q1 2023, up 23% quarter-over-quarter.
  • 19 funds opened new BioLife Solutions positions in Q1 2023 and 13 closed out, a net change of +6 holders.
  • The largest BioLife Solutions buyer in Q1 2023 was Park West Asset Management, an estimated $11.3M added.
  • The largest BioLife Solutions seller in Q1 2023 was Millennium Management, an estimated $4.29M sold.

Based on aggregated 13F filings for Q1 2023.